Predictive Oncology Inc. (NASDAQ:POAI) does about 1.20M shares in volume on a normal day but saw 775080 shares change hands in Thursday trading. The company now has a market cap of 19.78M USD and an enterprise value of about $21.65M. Its current market price is $1.53, marking a decrease of -3.16% compared to the previous close of $1.58. The 52 week high reached by this stock is $6.94 whilst the lowest price level in 52 weeks is $1.25. The script in recent trading has seen the stock touch a high of $1.58 and a low of $1.49.
Predictive Oncology Inc. (POAI) has a 20-day trading average at $1.5714 and the current price is -77.95% off the 52-week high compared with 22.40% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.6558 and its 200-day simple moving average is $2.3291. If we look at the stock’s price movements over the week, volatility stands at 10.45%, which decreases to 9.99% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 44.06 to suggest the stock is neutral.
The current price level is -2.67%, -7.52%, and -34.74% away from its SMA20, SMA50, and SMA200 respectively, with the POAI price moving above the 50-day SMA on July 30. Predictive Oncology Inc. (POAI) stock is down -6.71% over the week and -6.71% over the past month. Its price is -41.38% year-to-date and -76.46% over the past year.
Outstanding shares total 13.20M with insiders holding 32.68% of the shares and institutional holders owning 9.05% of the company’s common stock. The company has a return on investment of -145.20% and return on equity of -129.80%. The beta has a value of 1.63. Price to book ratio is 0.73 and price to sales ratio is 13.19.
According to a U.S. Securities and Exchange Commission filing, Vanguard Extended Market Index Fu has reduced its position in Predictive Oncology Inc. (POAI) to 34,404 shares, mirroring a recent drop by 0.00%. Vanguard Extended Market Index Fu dumped 0.0 shares of Predictive Oncology Inc. common stock bringing its total worth to about $56423.0 at the end of recent close, SEC documents show. Vanguard Extended Market Index Fu isn’t the only investment manager who changed stakes and is followed by Fidelity Extended Market Index Fu, which sold off 0.0 shares to end up with 2,723 shares worth $4466.0. USAA Extended Market Index Fund raise their holdings by 131.63% in the company over the course of the most recent quarter. It now holds a 0.01% position in Predictive Oncology Inc. thanks to 1450.0 shares amounting to $2378.0.